Dr. Steven Arnold Jenison, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1190 S Saint Francis Dr, Runnels Building S1150, Santa Fe, NM 87505 Phone: 505-476-3668 Fax: 505-827-0163 |
Linda Marie Gorgos, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 649 Harkle Rd Ste E, Santa Fe, NM 87505 Phone: 505-989-8200 Fax: 505-989-8131 |
Dr. Donald Alexander Romig, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 709 Copita Lane, Santa Fe, NM 87505 Phone: 505-988-5455 |
Linda Lucy Boulanger, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1700 Cerrillos Rd, Santa Fe, NM 87505 Phone: 505-988-9821 |
Dr. Shirley B Scott, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 428 Luisa Pl, Santa Fe, NM 87505 Phone: 505-986-9960 Fax: 505-988-1550 |
Dr. Joel Emanuel Gallant, M.D., M.P.H. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 649 Harkle Rd, Suite E, Santa Fe, NM 87505 Phone: 410-989-8200 |
Dr. Michael Dane Palestine, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 649 Harkle Rd Ste E, Santa Fe, NM 87505 Phone: 505-989-8200 Fax: 505-989-8131 |
Dr. David Freeman Gregory, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1700 Cerrillos Rd, Santa Fe, NM 87505 Phone: 505-946-9273 |
News Archive
Gene mutations in the HRAS sequence are present in most patients affected with Costello syndrome, according to a new study in the American Journal of Medical Genetics. The mutations occurred de novo in patients, meaning, they were not observed in their parents' genes.
Senate Finance Committee Chair Max Baucus (D-Mont.) and ranking member Chuck Grassley (R-Iowa) in a letter recently sent to HHS Secretary Mike Leavitt raised concerns about alleged problems in the Office of Medicare Hearings and Appeals, CQ HealthBeat reports.
MicroDose Therapeutx, Inc., announced today the completion of its third and final Phase 1 clinical study for MDT-637 with its novel inhaled antiviral fusion inhibitor, MDT-637, for the treatment of RSV infection.
Genomic Health, Inc. today announced that the company will present results from two studies at the American Society of Clinical Oncology (ASCO) 2009 Breast Cancer Symposium, taking place October 8 through October 10 at the San Francisco Marriott in San Francisco, California.
› Verified 2 days ago